title: Romiplostim (AMG531, Nplate) for secondary failure of platelet recovery after allo-SCT.
authors.forename: C
authors.initials: C
authors.lastname: Calmettes
authors.forename: S
authors.initials: S
authors.lastname: Vigouroux
authors.forename: R
authors.initials: R
authors.lastname: Tabrizi
authors.forename: N
authors.initials: N
authors.lastname: Milpied
mesh_terms: D000328:Adult; D001792:Blood Platelets; D005260:Female; D019337:Hematologic Neoplasms / Q000097:blood / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D038042:Myelopoiesis / Q000187:drug effects; D010976:Platelet Count; D011961:Receptors, Fc / Q000008:administration & dosage*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D020127:Recovery of Function; D013921:Thrombocytopenia / Q000209:etiology / Q000628:therapy*; D013926:Thrombopoietin / Q000008:administration & dosage*; D014184:Transplantation, Homologous
chemical_list: D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim